Jounce Therapeutics JNCE
$ 1.88
0.0%
Annual report 2022
added 04-28-2023
Country |
USA |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Richard Murray |
Employees in the company |
129 |
Shares |
51.7 M |
Market Cap[1] |
$ 98.4 M |
EBITDA (LTM) |
$ -98.6 M |
P/E (LTM) |
-0.55 |
P/S (LTM) |
0.34 |
EPS (LTM) |
-1.99 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.